24 Results for "

KCNQ1

" in MedChemExpress (MCE) Product Catalog:
Products (24)

24 Results for "KCNQ1" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-108577
CAS No.: 122955-13-9
Purity:  99.63%
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

XE991 dihydrochloride, a Kv7 (KCNQ) channels blocker, potently inhibits Kv7.1 (KCNQ1), Kv7.2 (KCNQ2), Kv7.2 + Kv7.3 (KCNQ3) channel, and M-current with IC50s of 0.75 μM, 0.71 μM, 0.6 μM, and 0.98 μM, respectively [1].
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-108577A
CAS No.: 122955-42-4
Purity:  99.62%
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

XE 991 dihydrochloride, a Kv7 (KCNQ) channels blocker, potently inhibits Kv7.1 (KCNQ1), Kv7.2 (KCNQ2), Kv7.2 + Kv7.3 (KCNQ3) channel, and M-current with IC50s of 0.75 μM, 0.71 μM, 0.6 μM, and 0.98 μM, respectively [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-12343
CAS No.: 1401242-74-7
Purity:  98.46%
Synonyms: CID-53347902
Target:  

Potassium Channel

Research Areas:  

Cardiovascular Disease

ML277 (CID-53347902) is a potent and selective activator of K(v)7.1 (KCNQ1) potassium channel activator (EC50=270 nM), rescues function of pathophysiologically important mutant channel complexes in human induced pluripotent stem cell-derived cardiomyocytes [1] .
loading...
    loading...
Cat. No.: HY-18063
CAS No.: 1392494-64-2
Research Areas:  

Neurological Disease

ML252 is a selective inhibitor of KCNQ2 (Kv7.2) channel with an IC50s of 69 nM, 2.92 μM, 0.12 μM and 0.20 μM for KCNQ2, KCNQ1 (Kv7.1), KCNQ2/Q3 and KCNQ4, respectively. ML252 also inhibits Cytochrome P450 with IC50s of 6.1 nM (CYP1A2), 18.9 nM (CYP2C9), 3.9 nM (CYP3A4), 19.9 nM (CYP2D6), respectively. ML252 shows highly brain penetrant [1] .
loading...
    loading...
Cat. No.: HY-108587
CAS No.: 325457-99-6
Purity:  99.85%
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

ICA 110381 is an orally active Kv7.2/Kv7.3 (KCNQ2/3) potassium channel activator with anticonvulsive properties. ICA 110381 is a KCNQ2/Q3 activator (EC50=0.38 μM) as well as KCNQ1 antagonist (IC50=15 μM) [1].
loading...
    loading...
Cat. No.: HY-108591
CAS No.: 103342-82-1
Purity:  99.67%
Synonyms: R-L3
Target:  

Potassium Channel

Research Areas:  

Cardiovascular Disease

L-364,373 (R-L3) is a voltage-gated Kv7.1 (KCNQ1)/mink channels activator. L-364,373 activates Iks (slow delayed rectifier potassium current) and shortens action potential duration in guinea pig cardiac myocytes, and suppresses early afterdepolarizations in rabbit ventricular myocytes [1].
loading...
    loading...
Cat. No.: HY-145992
CAS No.: 1008671-38-2
Purity:  99.03%
KCNQ1 activator-1 (compound 5) is a potent activator of KCNQ1 channel with an EC50 of 1.69 μM. KCNQ1 activator-1 has the potential for the research of long QT syndrome (LQTS) [1].
loading...
    loading...
Cat. No.: HY-108592
CAS No.: 918311-87-2
Purity:  98.91%
UCL 2077 is a potassium channel and slow afterhyperpolarization (sAHP) inhibitor. UCL 2077 selectively blocks sAHP channels without affecting L-type Ca 2+ currents. UCL 2077 blocks KCNQ1- and KCNQ2-containing K + channels, decreases erg current amplitude, increases erg deactivation rate. UCL 2077 can be used for the research of hippocampus-dependent memory retrieval deficit and cardiac arrhythmias [1] .
loading...
    loading...
Cat. No.: HY-RS07173
Research Areas:  

Others

KCNQ1 Human Pre-designed siRNA Set A contains three designed siRNAs for KCNQ1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-179065
CAS No.: 882235-30-5
Target:  

Potassium Channel

Research Areas:  

Cardiovascular Disease

VU0494372 is an activator of potassium ion channel KCNQ1. VU0494372 can significantly enhance the cell surface expression and transport efficiency of KCNQ1. VU0494372 does not alter KCNQ1 mRNA levels and protein degradation rate, and has no significant cytotoxicity. VU0494372 can be used for research on cardiovascular conditions [1].
loading...
    loading...
Cat. No.: HY-RS18286
Research Areas:  

Others

Kcnq1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Kcnq1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS24764
Research Areas:  

Others

Kcnq1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Kcnq1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-121977
CAS No.: 199335-15-4
Target:  

Potassium Channel

Research Areas:  

Inflammation/Immunology

IKs124 is KCNE2/KCNQ1 potassium channel blocker with the with an IC50 of 8 nM. IKs124 can be used for study of peptic ulcers [1].
loading...
    loading...
Cat. No.: HY-122504
CAS No.: 2764-03-6
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

Linoleoyl glycine is a modified polyunsaturated fatty acid. Linoleoyl glycine has activating effects on human KCNQ1/KCNE1 (hKCNQ1/hKCNE1) channels expressed in Xenopus oocytes [1].
loading...
    loading...
Cat. No.: HY-117174
CAS No.: 170228-29-2
Target:  

Potassium Channel

Research Areas:  

Cardiovascular Disease

L-735821 is a Potassium channel blocker and an antagonist of IKs. L-735821 inhibits the KCNQ1 channel activity with an EC50 of 0.08 μM. L-735821 can increase IKs and IKr current-voltage relations in rabbit ventricular myocytes. L-735821 fully abolishes IKs in isolated human ventricular myocytes at 100 nmol/L. L-735821 can easily enter single myocytes [1] .
loading...
    loading...
Cat. No.: HY-18063A
CAS No.: 2309887-61-2
Research Areas:  

Neurological Disease

ML252 hydrochloride is a selective inhibitor of KCNQ2 (Kv7.2) channel with IC50s of 69 nM, 2.92 μM, 0.12 μM and 0.20 μM for KCNQ2, KCNQ1 (Kv7.1), KCNQ2/Q3 and KCNQ4, respectively. ML252 hydrochloride also inhibits Cytochrome P450 with IC50s of 6.1 nM (CYP1A2), 18.9 nM (CYP2C9), 3.9 nM (CYP3A4), 19.9 nM (CYP2D6), respectively. ML252 hydrochloride shows highly brain penetrant [1] .
loading...
    loading...
Cat. No.: HY-108577R
CAS No.: 122955-13-9
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

XE991 dihydrochloride (Standard) is the analytical standard of XE991 dihydrochloride. This product is intended for research and analytical applications. XE991 dihydrochloride, a Kv7 (KCNQ) channels blocker, potently inhibits Kv7.1 (KCNQ1), Kv7.2 (KCNQ2), Kv7.2 + Kv7.3 (KCNQ3) channel, and M-current with IC50s of 0.75 μM, 0.71 μM, 0.6 μM, and 0.98 μM, respectively [1].
loading...
    loading...
Cat. No.: HY-184207
CAS No.: 119486-83-8
Zinc13732787 is an inhibitor of the KCNQ1/KCNE1 potassium channel complex, with no activity against the KCNQ2/KCNQ3 channel. Zinc13732787 reduces axonal growth in human neural stem cells, while exerting no effect on KCNQ1-knockout neural stem cells. Zinc13732787 can be used for research on arrhythmia, epilepsy, and neuropsychiatric disorders [1].
loading...
    loading...
Cat. No.: HY-108591R
CAS No.: 103342-82-1
Synonyms: R-L3 (Standard)
L-364,373 (Standard) is the analytical standard of L-364,373 (HY-108591). This product is intended for research and analytical applications. L-364,373 (R-L3) is a voltage-gated Kv7.1 (KCNQ1)/mink channels activator. L-364,373 activates Iks (slow delayed rectifier potassium current) and shortens action potential duration in guinea pig cardiac myocytes, and suppresses early afterdepolarizations in rabbit ventricular myocytes [1].
loading...
    loading...
Cat. No.: HY-121520
CAS No.: 132850-40-9
Docosahexaenoyl glycine is a PUFA analogue. Docosahexaenoyl glycine has activating effects on IKs channels and restore the function of IKs channels with LQT1 mutation [1].
loading...
    loading...